Inhibitors of Protein–Protein Interactions

Regular price €197.16
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
Age Group_Uncategorized
Age Group_Uncategorized
Ali
Andy
Arora
automatic-update
B01=Ali Tavassoli
Brown
Category1=Non-Fiction
Category=PHVN
Category=PNN
Category=PSBC
Category=PSD
COP=United Kingdom
David
Dehua
Delivery_Delivery within 10-20 working days
eq_bestseller
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
Eric
Grossmann
Hiroaki
Inhibitors
Interactions
Ivarsson
Language_English
Macrocycles
Marsault
Molecules
PA=Available
Paramjit
Pei
Peptides
Price_€100 and above
Protein-Protein
PS=Active
Rees
Small
softlaunch
Suga
Tavassoli
Tellers
Tom
Wilson
Ylva

Product details

  • ISBN 9781788015691
  • Weight: 694g
  • Dimensions: 156 x 234mm
  • Publication Date: 07 Dec 2020
  • Publisher: Royal Society of Chemistry
  • Publication City/Country: GB
  • Product Form: Hardback
  • Language: English
Secure checkout Fast Shipping Easy returns

Protein–protein interactions (PPI) are at the heart of the majority of cellular processes, and are frequently dysregulated or usurped in disease. Given this central role, the inhibition of PPIs has been of significant interest as a means of treating a wide variety of diseases. However, there are inherent challenges in developing molecules capable of disrupting the relatively featureless and large interfacial areas involved. Despite this, there have been a number of successes in this field in recent years using both traditional drug discovery approaches and innovative, interdisciplinary strategies using novel chemical scaffolds. This book comprehensively covers the various aspects of PPI inhibition, encompassing small molecules, peptidomimetics, cyclic peptides, stapled peptides and macrocycles. Illustrated throughout with successful case studies, this book provides a holistic, cutting-edge view of the subject area and is ideal for chemical biologists and medicinal chemists interested in developing PPI inhibitors.